α放射性药物
Search documents
美国IPO一周回顾及前瞻:上周有8家企业上市,8家企业递交上市申请
Sou Hu Cai Jing· 2026-01-12 08:10
Group 1: IPO Highlights - Aktis Oncology led the week with a large IPO, raising $318 million at a valuation of $1 billion, focusing on α-radiopharmaceuticals for solid tumors [1] - Buda Juice completed its IPO at the lower end of its price range, raising $20 million with a market cap of $95 million, emphasizing its "super fresh" juice category [2] - Atlas Critical Minerals also completed its IPO at the lower end, raising $10 million with a market cap of $40 million, focusing on mineral exploration in Brazil [2] Group 2: SPAC Activity - Five SPACs completed their IPOs, including Lafayette Digital Acquisition and Bleichroeder Acquisition II, each raising $250 million, targeting financial services and technology sectors [3] - Other SPACs like Art Technology Acquisition and Soren Acquisition raised $220 million and $150 million respectively, focusing on technology and healthcare [3] Group 3: Upcoming IPO Filings - Six companies filed for IPOs, including Brazilian digital bank PicS seeking $500 million and discount furniture retailer Bobs Discount Furniture aiming for $400 million [5] - Other notable filings include Forgent Power Solutions for $200 million and Eikon Therapeutics for $100 million, both in the healthcare sector [5] Group 4: Market Outlook - The IPO market is expected to be quiet in the upcoming week after the recent large IPO, with smaller issuers potentially joining the market [6] - Several large companies that have submitted IPO applications remain eligible to go public soon, including EquipmentShare.com and Motive Technologies [7]